VBI Vaccines (Nasdaq: VBIV) (“VBI”) announced that it will be presenting at the 2015 BIO International Convention on Wednesday, June 17th at 11:30 AM ET. Adam Buckley, VBI’s Vice President of Business Development, will discuss VBI’s eVLP and Thermostable LPV™ technologies, as well as opportunities for partnership.

The 2015 BIO International Convention will be held in Philadelphia, PA, and will host thousands of organizations, including leading life sciences companies, top CROs and CMOs, more than 300 academic institutions, and major research labs and government agencies.

To learn more visit: http://bit.ly/bio-2015